This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
The new online Learning Center with new content can still be found under the “Training” folder on ...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...